Yutaka Fujioka Selected Research

Yutaka Fujioka Research Topics

11	Neoplasms (Cancer) 02/2024 - 12/2013
11	Glioma (Gliomas) 02/2024 - 12/2019
8	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 12/2019
2	Disease Progression 06/2022 - 03/2022
2	Astrocytoma (Pilocytic Astrocytoma) 07/2021 - 12/2020
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2017 - 10/2017
2	Intracranial Aneurysm (Cerebral Aneurysm) 12/2017 - 10/2017
1	Clinical Deterioration 03/2022
1	Oligodendroglioma 07/2021
1	Central Nervous System Neoplasms 12/2020
1	Epilepsy (Aura) 12/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017
1	Aneurysm (Aneurysms) 10/2017
1	Carcinoma (Carcinomatosis) 01/2015
1	Microsatellite Instability 12/2013

5	Bevacizumab (Avastin)FDA Link 03/2022 - 02/2020
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2021 - 12/2013
3	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 12/2013
2	Cell-Free Nucleic AcidsIBA 02/2024 - 01/2023
2	GadoliniumIBA 08/2023 - 12/2019
2	Circulating Tumor DNAIBA 01/2023 - 03/2021
2	Histones (Histone)IBA 12/2020 - 01/2020
1	Protons (Proton)IBA 01/2024
1	Carmustine (FIVB)FDA Link 08/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2021
1	baysilon (polydimethylsiloxane)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	Monoclonal AntibodiesIBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 12/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	RE 102IBA 12/2019
1	Indicators and Reagents (Reagents)IBA 12/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2017
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2017

5	Craniotomy 08/2021 - 01/2015
2	Drug Therapy (Chemotherapy) 06/2022 - 07/2021
1	Ligation 01/2023
1	Chemoradiotherapy 09/2021
1	Immunotherapy 01/2021
1	Lab-On-A-Chip Devices 01/2021
1	Operative Surgical Procedures 10/2017
1	Perioperative Period 10/2017
1	Cerebral Revascularization 01/2015